Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
FBIOP:NASDAQ
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
$15.01
+7.06%
(+0.99) 1D
May 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIOP...
Open
$14.00
High
$15.49
Low
$13.85
Mkt. cap
80.06M
Avg. vol.
11.48K
Volume
71.02K
52-wk high
$15.49
52-wk low
$6.27
Beta
0.76
Shares outstanding
3.43M
No. of employees
78
News stories
From sources across the web
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Florida, United States
SectorBiotechnology
Websitefortressbiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
16.41M
17.63M
16.08M
16.04M
Cost of goods sold
13.06M
5.96M
5.07M
6.22M
Cost of revenue
13.06M
5.96M
5.07M
6.22M
Research and development expenses
-
-
-
540.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.76M
17.42M
14.73M
15.89M
Operating expense
39.82M
18.48M
15.80M
17.56M
Total operating expenses
52.89M
24.44M
20.87M
23.78M
Operating income
-36.47M
-6.81M
-4.79M
-7.74M
Other non operating income
-412.00K
32.74M
5.00K
152.83M
EBT including unusual items
-11.65M
8.85M
-6.21M
142.29M
EBT excluding unusual items
-38.78M
23.93M
-6.19M
142.29M
Income tax expense
-
26.00K
-816.00K
5.13M
Effective tax rate
-
0.29%
13.13%
3.61%
Other operating expenses
-
-
-
-
Net income
15.49M
5.85M
-3.94M
110.37M
Net profit margin
94.35%
33.18%
-24.49%
688.20%
Earnings per share
-0.51
-
-
-
Interest and investment income
622.00K
736.00K
637.00K
570.00K
Interest expense
-2.52M
-2.74M
-2.04M
-3.37M
Net interest expenses
-1.90M
-2.01M
-1.40M
-2.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-35.32M
-5.65M
-3.63M
-6.52M
Gain or loss from assets sale
-27.13M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer